All News

Everett Vokes, M.D. discusses what the future of immunotherapy might mean for patients with head and neck cancer.

Join us on Nov. 22 during the #CureConnect tweet chat to discuss facing the holidays with a cancer diagnosis.

Three recently-discovered molecular subtypes may help in crafting a more personalized treatment plan for men with prostate cancer.

Does PSA screening lead to an overtreatment of prostate cancer? Clayton S. Lau, M.D., discusses the topic.

We face loss everyday, and that's amplified this time of year--but there are things you can do to help.

Stress and depression can alter ovarian cancer tumors, often leading to poorer outcomes.

Cabometyx was proved to be superior to Sutent, reducing rates of disease progression or death for patients with metastatic RCC, according to a recent trial.

Thanks to recent clinical trials and FDA approvals, the treatment paradigm for multiple myeloma continues to shift.

Women who were vaccinated against HPV do not need to be screened for cervical cancer as often, according to a recent study.

Take back control in the midst of an uncontrolled situation.

Routine checkups can rattle us with technology and subconscious fears that tiptoe to the surface, even five years out. Perhaps going alone to important screenings is not the best idea. Taking a friend if you do not have a partner, even if you can do it all alone, is never a bad idea.

The future of multiple myeloma treatment may be in immunotherapy combinations, according to Eric L. Smith, M.D., Ph.D.

Intratumoral SD-101 and Keytruda proved to be well-tolerated for patients with early stage melanoma, according to the results of a recent study.

An expert sat down with CURE to discuss standard therapies for localized prostate cancer.

Midostaurin was granted a priority review for a new drug application by the FDA to treat a subset of patients with acute myeloid leukemia.

Breast cancer and melanoma survivor gets out of her thoughts by getting outdoors and re-prioritizing her life.

Cancer jargon is sometimes lost in translation.

According to results from a recent study, Keytruda had longer overall survival (OS) when compared to chemotherapy for patients with bladder cancer.

The NCCN updated their guidelines on treatment for myeloproliferative neoplasms (MPNs), outlining diagnosis, treatment and care strategies.

Leena Gandhi discusses current and emerging treatment strategies for patients with ALK-rearranged lung cancer.

One woman's experience with her oncologist when the time came around for a mammogram.

It can be hard to name our fears, especially when we are worried that others don't share them or that they will make us feel like a part of our community. In sharing, we can name stressors, activate healing from those stressors and give our bodies a chance to cope with all that has happened to us.

Tumor-treating fields are having a huge impact on the treatment and outcomes of patients with glioblastoma multiforme (GBM).

Stivarga is being considered by the FDA for approval for second-line liver cancer treatment, renewing hope in the field.

Kimberly Blackwell, M.D., discusses advancements in the field of HER2+ breast cancer.